Since most kidney transplant recipients are histoincompatible with donor tissues, recipients must be immunosuppressed to prevent graft rejection. Of the several immunosuppressive procedures currently favored, two are relatively new and particularly intriguing: 1) Cyclosporine (CsA) therapy, and 2) pre-operative donor-specific blood transfusions (DST). The in vivo mechanisms by which these procedures prevent or attenuate allograft rejection remain speculative. We propose a series of studies designed to quantitate T cell functions that develop at a graft site, and to identify the alterations in these functions induced by CsA and DST. These studies will employ an established murine allograft model, the sponge matrix allograft, to investigate 1) the composition of graft-infiltrating lymphoid populations at various times after graft implantation as determined by morphologic, histologic and serologic criteria, 2) the cytolytic activity and population size of cytolytic T cells which accumulate at the graft site at various times after graft implantation as detected by direct cytolysis and limiting dilution analysis, 3) the helper T cell activity which accumulates at the graft site at various times after graft implantation as determined by analysis of sponge effluents and sponge-infiltrate T cell products for various lymphokines (IL-2, IL-3, MAF, CSF), and by limiting dilution analysis of helper T cell frequency, 4) the identity of any suppressive activity which develops at the graft site during allograft rejection, 5) the T cell-mediated events which develop in sponge allografts from Class I or Class II MHC-disparate congenic recombinant donor-recipient combinations, 6) the influence of systematically administered Cyclosporine on the composition and T cell functions of allograft infiltrating cells, and 7) the influence of DST on the composition and T cell functions of allograft infiltrating cells. In part, these studies will serve as in vivo tests of hypotheses concerning allorecognition which have developed from in vitro studies. In addition, they should provide considerable information regarding the requisite in situ components of allograft rejection. Finally, they provide a practical experimental model with which in vivo effects of various immunosuppressive therapies can be determined. Information thus obtained may suggest ways to optimize existing immunosuppressive protocols and, perhaps, may suggest new, more effective immunotherapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034774-03
Application #
3233018
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-12-01
Project End
1988-07-31
Budget Start
1986-12-01
Budget End
1988-07-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Orosz, C G; Huang, E H; Bergese, S D et al. (1997) Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. J Heart Lung Transplant 16:889-904
Bergese, S D; Huang, E H; Pelletier, R P et al. (1995) Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. Am J Pathol 147:166-75
VanBuskirk, A M; Adams, P W; Orosz, C G (1995) Nonradioactive alternative to clinical mixed lymphocyte reaction. Hum Immunol 43:38-44
Orosz, C G; Bergese, S D; Huang, E H et al. (1995) Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy. Transplant Proc 27:387-8
Dahmen, U; Bergese, S D; Qian, S et al. (1995) Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation 60:577-84
Bergese, S D; Pelletier, R P; Ferguson, R M et al. (1995) Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice. Transplant Proc 27:480-1
Bergese, S; Pelletier, R; Vallera, D et al. (1995) Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4. Am J Pathol 146:989-98
Huang, E H; Gabler, D M; Krecic, M E et al. (1994) Differential effects of gallium nitrate on T lymphocyte and endothelial cell activation. Transplantation 58:1216-22
Bergese, S D; Pelletier, R P; Ohye, R G et al. (1994) Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression. Transplantation 57:711-7
Huang, E H; Morgan, C J; Sedmak, D D et al. (1994) Alloantigenicity of human endothelial cells. IV. Derivation, characterization, and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions. Transplantation 57:703-11

Showing the most recent 10 out of 22 publications